Collage photo of Stephen Liu and Noemi Reguart
May 11, 2025, 15:36
Stephen Liu: Noemi Reguart Discusses PD1/VEGF Bispecifics in NSCLC at Rome Lung 2025
Stephen Liu, Director of Thoracic Oncology, Head of Developmental Therapeutics and Associate Professor at Georgetown Lombardi Comprehensive Cancer Center, shared a post on X:
“Dr. Noemi Reguart discusses PD1/VEGF bispecifics in NSCLC at Rome Lung 2025. Many compounds in development- ivonescimab and BNT-327 furthest along. Encouraging results from HARMONi-2. Will cooperative binding and complex formation lead to better survival? Need to see full results here.”
More posts featuring Stephen Liu.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jul 16, 2025, 17:55
Jul 16, 2025, 17:38
Jul 16, 2025, 17:37
Jul 16, 2025, 17:04
Jul 16, 2025, 16:51
Jul 16, 2025, 16:34
Jul 16, 2025, 16:18